Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Project: EVO Monitor Sensitivity to Methylphenidate and Triazolam
NCT02822937Completed
- Sponsor
- Akili Interactive
- Start
- Jul 2016
- Primary completion
- Nov 2016
- Countries
- 1
01
Overview
Randomised trial (6 arms), sponsored by Akili Interactive. Primary endpoints: Intra-subject sensitivity of Project: EVO cognitive measurements (threshold based) to a cognitive enhancer or a cognitive disruptor at peak drug effects relative to placebo and Intra-subject sensitivity of Project: EVO cognitive measurements (reaction time based) to a cognitive enhancer or a cognitive disruptor at peak drug effects relative to placebo. Started Jul 2016; status: completed.
Beyond the preview
Go deeper on NCT02822937.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02822937.